Literature DB >> 19277060

Charcot-Marie-Tooth disease.

Kinga Szigeti1, James R Lupski.   

Abstract

Charcot-Marie-Tooth (CMT) disease is a heterogeneous group of genetic disorders presenting with the phenotype of a chronic progressive neuropathy affecting both the motor and sensory nerves. During the last decade over two dozen genes have been identified in which mutations cause CMT. The disease illustrates a multitude of genetic principles, including diverse mutational mechanisms from point mutations to copy number variation (CNV), allelic heterogeneity, age-dependent penetrance and variable expressivity. Population based studies have determined the contributions of the various genes to disease burden enabling evidence-based approaches to genetic testing.

Entities:  

Mesh:

Year:  2009        PMID: 19277060      PMCID: PMC2947101          DOI: 10.1038/ejhg.2009.31

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  46 in total

1.  Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A.

Authors:  Stephan Züchner; Irina V Mersiyanova; Maria Muglia; Nisrine Bissar-Tadmouri; Julie Rochelle; Elena L Dadali; Mario Zappia; Eva Nelis; Alessandra Patitucci; Jan Senderek; Yesim Parman; Oleg Evgrafov; Peter De Jonghe; Yuji Takahashi; Shoij Tsuji; Margaret A Pericak-Vance; Aldo Quattrone; Esra Battaloglu; Alexander V Polyakov; Vincent Timmerman; J Michael Schröder; Jeffery M Vance; Esra Battologlu
Journal:  Nat Genet       Date:  2004-04-04       Impact factor: 38.330

2.  Early recognition of hereditary motor and sensory neuropathy type 1 can avoid life-threatening vincristine neurotoxicity.

Authors:  R Naumann; J Mohm; U Reuner; F Kroschinsky; B Rautenstrauss; G Ehninger
Journal:  Br J Haematol       Date:  2001-11       Impact factor: 6.998

3.  Charcot-Marie-Tooth disease and related neuropathies: mutation distribution and genotype-phenotype correlation.

Authors:  Cornelius F Boerkoel; Hiroshi Takashima; Carlos A Garcia; Richard K Olney; John Johnson; Katherine Berry; Paul Russo; Shelley Kennedy; Ahmad S Teebi; Mena Scavina; Lowell L Williams; Pedro Mancias; Ian J Butler; Karen Krajewski; Michael Shy; James R Lupski
Journal:  Ann Neurol       Date:  2002-02       Impact factor: 10.422

Review 4.  Use of anticonvulsants for treatment of neuropathic pain.

Authors:  Misha-Miroslav Backonja
Journal:  Neurology       Date:  2002-09-10       Impact factor: 9.910

5.  Mutational analysis of PMP22, MPZ, GJB1, EGR2 and NEFL in Korean Charcot-Marie-Tooth neuropathy patients.

Authors:  Byung-Ok Choi; Mi Sun Lee; Sang Hee Shin; Jung Hee Hwang; Kyoung-Gyu Choi; Won-Ki Kim; Il Nam Sunwoo; Nam Keun Kim; Ki Wha Chung
Journal:  Hum Mutat       Date:  2004-08       Impact factor: 4.878

6.  Charcot-Marie-Tooth disease: data for genetic counseling relating age to risk.

Authors:  T D Bird; G H Kraft
Journal:  Clin Genet       Date:  1978-07       Impact factor: 4.438

7.  Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A).

Authors:  Michael W Sereda; Gerd Meyer zu Hörste; Ueli Suter; Naureen Uzma; Klaus-Armin Nave
Journal:  Nat Med       Date:  2003-11-09       Impact factor: 53.440

8.  Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot-Marie-Tooth disease.

Authors:  A Jordanova; P De Jonghe; C F Boerkoel; H Takashima; E De Vriendt; C Ceuterick; J-J Martin; I J Butler; P Mancias; S Ch Papasozomenos; D Terespolsky; L Potocki; C W Brown; M Shy; D A Rita; I Tournev; I Kremensky; J R Lupski; V Timmerman
Journal:  Brain       Date:  2003-03       Impact factor: 13.501

9.  Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease.

Authors:  Edith Passage; Jean Chrétien Norreel; Pauline Noack-Fraissignes; Véronique Sanguedolce; Josette Pizant; Xavier Thirion; Andrée Robaglia-Schlupp; Jean François Pellissier; Michel Fontés
Journal:  Nat Med       Date:  2004-03-21       Impact factor: 53.440

10.  Mutations in MTMR13, a new pseudophosphatase homologue of MTMR2 and Sbf1, in two families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease associated with early-onset glaucoma.

Authors:  H Azzedine; A Bolino; T Taïeb; N Birouk; M Di Duca; A Bouhouche; S Benamou; A Mrabet; T Hammadouche; T Chkili; R Gouider; R Ravazzolo; A Brice; J Laporte; E LeGuern
Journal:  Am J Hum Genet       Date:  2003-04-08       Impact factor: 11.025

View more
  61 in total

1.  Jean-Martin Charcot: the father of neurology.

Authors:  David R Kumar; Florence Aslinia; Steven H Yale; Joseph J Mazza
Journal:  Clin Med Res       Date:  2010-08-25

2.  Mutations in VRK1 associated with complex motor and sensory axonal neuropathy plus microcephaly.

Authors:  Claudia Gonzaga-Jauregui; Timothy Lotze; Leila Jamal; Samantha Penney; Ian M Campbell; Davut Pehlivan; Jill V Hunter; Suzanne L Woodbury; Gerald Raymond; Adekunle M Adesina; Shalini N Jhangiani; Jeffrey G Reid; Donna M Muzny; Eric Boerwinkle; James R Lupski; Richard A Gibbs; Wojciech Wiszniewski
Journal:  JAMA Neurol       Date:  2013-12       Impact factor: 18.302

Review 3.  Mitochondrial disorders of DNA polymerase γ dysfunction: from anatomic to molecular pathology diagnosis.

Authors:  Linsheng Zhang; Sherine S L Chan; Daynna J Wolff
Journal:  Arch Pathol Lab Med       Date:  2011-07       Impact factor: 5.534

Review 4.  New insights into the pathophysiology of pes cavus in Charcot-Marie-Tooth disease type 1A duplication.

Authors:  José Berciano; Elena Gallardo; Antonio García; Ana L Pelayo-Negro; Jon Infante; Onofre Combarros
Journal:  J Neurol       Date:  2011-05-18       Impact factor: 4.849

5.  Whole-Exome Sequencing Identifies a Novel Homozygous Frameshift Mutation in the MTMR2 Gene as a Causative Mutation in a Patient with Charcot-Marie-Tooth Disease Type 4B1.

Authors:  Tameemi Abdalla-Moady; Amir Peleg; Orit Sadeh; Khader Badarneh; Fuad Fares
Journal:  Mol Neurobiol       Date:  2017-05-16       Impact factor: 5.590

6.  Muscle spindle alterations precede onset of sensorimotor deficits in Charcot-Marie-Tooth type 2E.

Authors:  E Villalón; M R Jones; C Sibigtroth; S J Zino; J M Dale; D S Landayan; H Shen; D D W Cornelison; M L Garcia
Journal:  Genes Brain Behav       Date:  2016-10-11       Impact factor: 3.449

Review 7.  Consequences of Rab GTPase dysfunction in genetic or acquired human diseases.

Authors:  Marcellus J Banworth; Guangpu Li
Journal:  Small GTPases       Date:  2017-12-28

8.  Dominant GDAP1 founder mutation is a common cause of axonal Charcot-Marie-Tooth disease in Finland.

Authors:  Mari Auranen; Emil Ylikallio; Jussi Toppila; Mirja Somer; Sari Kiuru-Enari; Henna Tyynismaa
Journal:  Neurogenetics       Date:  2013-03-03       Impact factor: 2.660

Review 9.  Diagnosis of Charcot-Marie-Tooth disease.

Authors:  Isabel Banchs; Carlos Casasnovas; Antonia Albertí; Laura De Jorge; Mónica Povedano; Jordi Montero; Juan Antonio Martínez-Matos; Victor Volpini
Journal:  J Biomed Biotechnol       Date:  2009-10-08

10.  Exome Sequence Analysis Suggests that Genetic Burden Contributes to Phenotypic Variability and Complex Neuropathy.

Authors:  Claudia Gonzaga-Jauregui; Tamar Harel; Tomasz Gambin; Maria Kousi; Laurie B Griffin; Ludmila Francescatto; Burcak Ozes; Ender Karaca; Shalini N Jhangiani; Matthew N Bainbridge; Kim S Lawson; Davut Pehlivan; Yuji Okamoto; Marjorie Withers; Pedro Mancias; Anne Slavotinek; Pamela J Reitnauer; Meryem T Goksungur; Michael Shy; Thomas O Crawford; Michel Koenig; Jason Willer; Brittany N Flores; Igor Pediaditrakis; Onder Us; Wojciech Wiszniewski; Yesim Parman; Anthony Antonellis; Donna M Muzny; Nicholas Katsanis; Esra Battaloglu; Eric Boerwinkle; Richard A Gibbs; James R Lupski
Journal:  Cell Rep       Date:  2015-08-06       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.